Skip to main content
Premium Trial:

Request an Annual Quote

ABI to Sell Mass Spec Manufacturing Facility to Delphi Medical Systems

NEW YORK, June 9 (GenomeWeb News) - In another step of its ongoing reorganization, Applied Biosystems is selling its Texas-based mass spectrometry manufacturing facility to Delphi Medical Systems, a multi-faceted instrument manufacturer, according to people familiar with the transaction.

 

The deal, which was to have closed on June 6, will be announced June 9, according to one of these individuals.

 

Based in Stafford, on the outskirts of Houston, ABI's facility employs around 50 people. The 50,000-square-foot facility manufactures mass specs and related software, protein sequencers, peptide- and DNA-synthesis products, and cell-detection instruments, she said.

 

Financial terms of the deal or the status of the employees were not immediately known.

 

A spokesperson for ABI confirmed the sale, but did not elaborate. She referred a GenomeWeb News reporter to a second spokesperson, who did not immediately return a telephone call seeking comment.

The sale of the facility is consistent with an ongoing restructuring at ABI, especially in its proteomic instrument business. Last September, the company transferred its Voyager MALDI-TOF and 4700 MALDI-TOF/TOF instruments, made in Houston, to its joint venture with MDS. The joint venture already produces a number of mass spectrometers sold by ABI, which will continue to market, sell, and service the systems.

R&D and manufacturing of the Voyager and 4700 mass spectrometers --- the only ones that ABI manufactured in-house at the time --- and related intellectual property will be moved to the ABI/MDS Sciex Instruments joint venture in Toronto.

As part of that deal, manufacturing will move from ABI's facility to MDS Sciex. In addition, ABI has reduced its MALDI R&D group in Framingham, Mass., by an undisclosed number of people and will transfer the remainder of the group to Toronto. All future MALDI-TOF-based mass spec systems will be developed in Toronto.
 
Delphi Medical Systems, based in
Troy, Mich., manufactures instruments for dialysis, infusion, in vitro diagnostics, respiratory care, and equipment for monitoring vital signs, according to its web site.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.